Status:
COMPLETED
Dyslipidemia and Diabetic Retinopathy
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Diabetic Retinopathy
Dyslipidemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.
Detailed Description
The purpose of this study is to determine if the reparative cells of blood vessels, called endothelial progenitor cells (EPC's) are defective in people with diabetes. Diabetic retinopathy (DR) is an e...
Eligibility Criteria
Inclusion
- Any man or woman
- Greater than 18 years of age
- Diagnosis of diabetes (applies to the Diabetic Arm only) (N=15 Type 1 and N=15 Type
- The subject must be willing and have the ability to cooperate with the protocol. Children will not be eligible because the investigators need to obtain 150 ml of blood and this is in excess of what can be drawn in children.
Exclusion
- Female participants must not be pregnant at the time of the blood draw as evident through a dipstick pregnancy test.
- Have retinal abnormalities other than diabetic retinopathy.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03403283
Start Date
January 1 2014
End Date
April 30 2023
Last Update
May 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294